A non-invasive end-to-end intelligent assistance system for breast ultrasound
Summary
An end-to-end breast intelligent recognition device (BIRD) has been developed and tested to address generalization challenges in breast ultrasound diagnosis. BIRD achieved an internal test set accuracy of 0.837 (95% confidence interval: 0.827–0.846), significantly improving radiologists' accuracy in two reader studies (*P* < 0.05). The system was applied in breast cancer screening for 6,817 individuals across 107 hospitals, demonstrating high consistency with clinical assessments (Cohen's kappa: 0.702 (95% confidence interval: 0.628-0.777)). Additionally, pathological and molecular subtype models, trained with data from five hospitals, showed satisfactory classification performance. These findings confirm BIRD's capability to enhance diagnostic accuracy, aid screening, and characterize breast lesions, supporting its clinical adoption.
Key takeaway
For healthcare administrators evaluating AI diagnostic tools, BIRD presents a validated solution for breast ultrasound. Its demonstrated accuracy of 0.837 and high consistency (Cohen's kappa: 0.702) across 107 hospitals suggest it can significantly enhance diagnostic efficiency and screening programs. Consider piloting BIRD or similar end-to-end AI systems to improve patient outcomes and streamline breast health practices in your institution.
Key insights
BIRD significantly improves breast ultrasound diagnostic accuracy and screening consistency across diverse real-world clinical settings.
Principles
- AI can overcome generalization challenges in medical imaging.
- Real-world deployment validates AI diagnostic tools.
- Pathological and molecular models enhance lesion characterization.
Method
The BIRD system was developed and tested end-to-end across diverse institution/population datasets, then applied in breast cancer screening for 6,817 individuals across 107 hospitals.
In practice
- Integrate BIRD for improved diagnostic accuracy.
- Utilize BIRD for large-scale breast cancer screening.
- Employ AI for pathological and molecular subtyping.
Topics
- Breast Ultrasound
- Artificial Intelligence
- Medical Diagnostics
- Breast Cancer Screening
- Clinical Validation
- Image Classification
Best for: Computer Vision Engineer, AI Scientist, Research Scientist, Domain Expert
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.